本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

140.25
-4.6350-3.20%
成交量:31.60万
成交额:4,475.47万
市值:90.75亿
市盈率:136.16
高:146.00
开:146.00
低:139.98
收:144.88
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:0.70
换手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:10.78
市盈率(LYR):-68.41

数据加载中...

2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/02

重要事件披露

8-K/A [Amend] - Current report
2020/09/11

重要事件披露

8-K - Current report
2020/08/13

重要事件披露

8-K - Current report
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/06/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/29

重要事件披露

8-K - Current report
2020/05/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/12

重要事件披露

8-K - Current report